Skip to main content
DECIDR AI INDUSTRIES LTD logo

DECIDR AI INDUSTRIES LTD — Investor Relations & Filings

Ticker · DAI ISIN · AU0000386310 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 322 across all filing types
Latest filing 2021-07-26 Interim / Quarterly Rep…
Country AU Australia
Listing ASX DAI

About DECIDR AI INDUSTRIES LTD

https://decidrindustries.ai/

DECIDR AI INDUSTRIES LTD is a technology firm specializing in the development of advanced artificial intelligence systems designed to automate and optimize complex decision-making processes. The company provides a proprietary AI platform that enables organizations to integrate autonomous decision logic into their existing workflows, reducing manual intervention and increasing operational efficiency. Its core offerings focus on decision intelligence, leveraging machine learning and algorithmic frameworks to process large-scale data sets and execute real-time actions. DECIDR's solutions are primarily targeted at enterprise-level clients seeking to scale their operations through intelligent automation. By prioritizing the execution of logic-based outcomes over simple data visualization, the company positions itself as a provider of end-to-end autonomous business infrastructure.

Recent filings

Filing Released Lang Actions
LV1 June 2021 Quarterly Business Review & Appendix 4C 12 pages 475.3KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX release dated 27 July 2021, titled 'LV1 June 2021 Quarterly Business Review & Appendix 4C'. It contains detailed quarterly operational and financial information, including sales highlights, cash receipts, expenditure breakdowns, operational updates, management changes, and a full Appendix 4C cash flow report for the quarter ended 30 June 2021. The Appendix 4C is a recognized quarterly cash flow report required by the ASX Listing Rules. The document is approximately 15,000 characters long, indicating it is a substantive report rather than a brief announcement. The content includes actual financial data and analysis for a quarter, consistent with an Interim / Quarterly Report. Therefore, the document should be classified as an Interim / Quarterly Report (IR). Q4 2021
2021-07-26 English
Distribution of TheraJoint on Amazon Australia Marketplace 3 pages 172.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX release dated 22 July 2021 announcing the commencement of distribution of a product (TheraJoint+) on the Amazon Australia marketplace. It discusses business strategy, market growth, and product availability but does not contain financial statements, audit information, management changes, or regulatory filings. It is a corporate announcement about a commercial development and distribution channel expansion. It does not fit into categories like Annual Report, Earnings Release, or Capital Update. It is not a report or presentation but a business update announcement. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-07-21 English
Change in substantial holding 2 pages 109.6KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001. It details changes in voting power and shareholdings of a substantial shareholder, including dates and nature of transactions. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the Major Shareholding Notification category. The document is not a financial report, earnings release, or management report, but a regulatory disclosure of shareholding changes.
2021-07-18 English
Appendix 3G 14 pages 308.7KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3G form submitted to the ASX, which is a notification of the issue, conversion, or payment up of equity securities. It details the issuance of unquoted options under an employee incentive scheme, including the number of securities, security type, and other related information. This type of filing is a formal announcement regarding changes in the company's capital structure, specifically the issuance of new securities. It is not a financial report, earnings release, or management discussion, but rather a capital/financing update. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail confirm it is the announcement itself, not a mere report publication announcement or regulatory filing.
2021-07-15 English
ASX Clarification Announcement 1 page 134.2KB
Regulatory Filings Classification · 95% confidence The document is an ASX Clarification Announcement dated 14 July 2021, clarifying details about a previous sales campaign announcement made on 12 July 2021. It provides specific sales figures and marketing plans but does not contain financial statements or detailed financial analysis. The document is short (2076 characters) and serves as a clarification or update rather than a full financial report or earnings release. It does not fit categories like Annual Report, Earnings Release, or Interim Report. It is an announcement related to sales and marketing updates, which aligns best with a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-07-13 English
Launch of first TGA registered Product - TheraJoint 4 pages 227.9KB
Regulatory Filings Classification · 90% confidence The document is an ASX release dated 12 July 2021 announcing the launch and first sales of a new product, TheraJoint+, by Live Verdure Ltd. It details the product's development, TGA approval, market potential, and company strategy. There are no financial statements, quarterly or annual results, or regulatory filings referenced. The content is a corporate announcement about product launch and sales commencement, which fits the category of a Capital/Financing Update or general corporate update. However, since it focuses on product launch and sales commencement rather than fundraising or capital structure changes, it is best classified as a Regulatory Filing (RNS) as a general announcement that does not fit other specific categories.
2021-07-11 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.